| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004746 | American Journal of Ophthalmology | 2007 | 7 Pages |
Abstract
Verteporfin PDT is a promising treatment modality resulting in stable or improved vision in 76% of the myopic eyes with juxtafoveal CNV. Younger patients appear to respond more favorably to treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Alfredo MD, Maria MD, PhD, Vincenzo MD, Domenica MD,